IC
EOLS icon

Ikarian Capital’s Evolus EOLS Stock Holding History

Ikarian Capital’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-193,265
Closed -$2.32M – 157
2025
Q1 		$2.32M Sell
193,265
-180,000
-48% -$2.35M 0.29% 67
2024
Q4 		$4.12M Buy
373,265
+114,986
+45% +$1.62M 0.56% 50
2024
Q3 		$4.18M Buy
+258,279
New +$3.61M 0.58% 54
2022
Q3 		– Sell
-45,516
Closed -$529K – 127
2022
Q2 		$529K Buy
+45,516
New +$537K 0.1% 104

Other funds holding EOLS

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ikarian Capital's EOLS Position: Q2 2025 in Review

Ikarian Capital sold out of Evolus (EOLS) in Q2 2025, closing a stake of 193,265 shares — an estimated $2.32M sold.

Ikarian Capital first reported a position in EOLS in Q2 2022 and held it in 4 quarters. The position peaked at $4.18M in Q3 2024. 172 funds tracked by Wall St. Rank hold EOLS as of Q2 2025.

  • Ikarian Capital reported no remaining Evolus position as of Q2 2025 after selling out during the quarter.
  • Ikarian Capital sold 193,265 Evolus shares in Q2 2025, an estimated $2.32M.
  • Ikarian Capital first reported a position in Evolus in Q2 2022 and held it in 4 quarters.
  • Ikarian Capital's Evolus position peaked at $4.18M in Q3 2024.
  • 172 funds tracked by Wall St. Rank held Evolus as of Q2 2025.

Based on Ikarian Capital's 13F filing for Q2 2025, filed 14 Aug 2025.